BACKGROUND
The effect of transcatheter tricuspid-valve repair on clinical outcomes, including death and hospitalization for heart failure, in patients with severe tricuspid regurgitation remains uncertain.
METHODS
We randomly assigned patients with symptomatic severe tricuspid regurgitation and an increased risk of f...
J. Hausleiter, T. Stocker, Tobias Geisler et al.· New England Journal of Medic...· 5 citations· ⚡1
BACKGROUND
In patients undergoing tricuspid valve transcatheter edge-to-edge repair (T-TEER) for tricuspid regurgitation (TR), NYHA functional class guides assessment, but real-world data on its prognostic value and determinants of symptomatic response remain limited.
OBJECTIVES
The objective of the study was to asse...
Charlotte Wolff, P. Sagmeister, K. Fengler et al.· JACC: Advances· 0 citations
One-year MiCLASP results support the safety of mitral transcatheter edge-to-edge repair with the PASCAL system in both AFMR and VFMR, with comparable echocardiographic, functional, and quality-of-life changes, despite baseline differences in clinical presentation.
A. Mahabadi, T. Rassaf, T. Kister et al.· Circulation. Cardiovascular...· 0 citations
After effective TR reduction (residual TR <I; n=341, 52%), no RV cut-off remained associated with survival, and effective TR reduction attenuated this prognostic value.
J. Althoff, Jennifer von Stein, Philipp von Stein et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
